Dopa-responsive dystonia: Guanosine triphosphate cyclohydrolase 1, tyrosine hydroxylase, and sepiapterin reductase

CC BY-NC-ND 4.0 · Ibnosina Journal of Medicine and Biomedical Sciences 2021; 13(01): 44-45
DOI: 10.4103/ijmbs.ijmbs_23_21

Letter to Editor

Jamir Pitton

Department of Medicine, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil

,

Ana Caprara

Department of Medicine, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil

References
1 Etarhuni SA, Zeglam AM, Elbouaishi AS, Sharfddin AM. Nephrocalcinosis in genetically proved dopa-responsive dystonia due to sepiapterin reductase deficiency in a Libyan Girl. Ibnosina J Med Biomed Sci 2020;12:315-9.
2 Mishra S, Mallick AK, Panigrahy D, Nayak P, Biswal NR. Series of dopa responsive dystonia masquerading as other diseases with short review. J Pediatr Neurosci 2020;15:421-5.
3 Rissardo JP, Caprara AL. Mirtazapine-associated movement disorders: A literature review. Tzu Chi Med J 2020;32:318-30.
4 Shalash AS, Rösler TW, Müller SH, Salama M, Deuschl G, Müller U, et al. c. 207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystonia. Neurol Genet 2017;3:e197.
5 AlSubhi S, AlShahwan S, AlMuhaizae M, AlZaidan H, Tabarki B. Sepiapterin reductase deficiency: Report of 5 new cases. Eur J Paediatr Neurol 2017;21:583-6.
6 Banerjee S, Sinha SK, Varshney PG, Ahuja P. Anaesthetic management of a child with Lesch Nyhan syndrome. Indian J Anaesth 2019;63:1051-2.
7 Rissardo JP, Caprara AL. Dystonia and adrenoleukodystrophy: An overview. Ann Mov Disord 2020;3:65-6.
8 Kulkarni SD, Kothari SR. Pediatric movement disorders and neuromodulation: An overview. Neurol India 2020;68:S206-12.